Cruchaga, Carlos

TOPMed imputed genomics enhances genomic atlas of the human proteome in brain, cerebrospinal fluid, and plasma

Yi, H., Yang, Q., Repaci, C., Lee, C. M., Heo, G., Timsina, J., Gorijala, P., Yang, C., Budde, J., Wang, L., et al. (2024) · Scientific Data

Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals

Cited by 5

Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel disease

Debette, S., Caro, I., Western, D., Namba, S., Sun, N., Kawaguchi, S., He, Y., Fujita, M., Roshchupkin, G., D'Aoust, T., et al. (2024) · Research Square

Cerebrovascular and genetic disordersMultiple Sclerosis Research Studies

Cited by 5

Patient stratification by genetic risk in Alzheimer’s disease is only effective in the presence of phenotypic heterogeneity

Euesden, J., Ali, M., Robins, C., Surendran, P., Gormley, P., (ADNI), F. T. A. D. N. I., Pulford, D., & Cruchaga, C. (2025) · PLOS ONE

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 3

P4–329: A rare coding variant alters UNC5C function and predisposes to Alzheimer's disease

Hunkapiller, J., Wetzel, M., Bhangale, T., Maloney, J., Atwal, J., Ortmann, W., Tessier‐Lavigne, M., Goate, A., Behrens, T., Cruchaga, C., et al. (2013) · Alzheimer's & Dementia

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 3

Study of blood linear RNA nominates CD55 and DLD as early-stage biomarkers for Parkinson's disease

Beric, A., Sahin, S., Sanchez, S., Yang, Z., Kumar, R., Alfradique-Dunham, I., Sanford, J., Western, D., Phillips, B., Budde, J. P., et al. (2026) · Brain

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 2

Genetic and glial heterogeneity in Alzheimer disease

Brase, L., You, S., Novotny, B. C., Soriano‐Tarraga, C., Morris, J. C., Bateman, R. J., Perrin, R. J., McDade, E., Goate, A., Karch, C. M., et al. (2022) · Alzheimer's & Dementia

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 1

Low overlap of plasma and CSF protein quantitative trait loci affects protein discovery for neurological disease

Western, D., Yang, C., Timsina, J., Liu, M., Wang, C., Campbell, M. C., Kotzbauer, P., Perlmutter, J. S., Schindler, S. E., Morris, J. C., et al. (2026) · Science Translational Medicine

Genetic Associations and EpidemiologyMultiple Sclerosis Research Studies

Cited by 1